Last reviewed · How we verify
NCT07191795: PhantomWalk
Uses of Phantom Sensations Induced by Global and Local Modifications of the Prosthetic Socket as Somatosensory Feedback During Walking in Lower Limb Amputees
NA trial testing Gait analysis in Lower Limb Amputation in 228 participants. Currently enrolling.
30 September 2028
Quick facts
| Lead sponsor | Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 228 |
| Start date | 16 September 2024 |
| Primary completion | 30 September 2028 |
| Estimated completion | 30 September 2030 |
| Sites | 1 location across France |
Drugs / interventions tested
- Gait analysis
- Mapping of referred sensations.
- Exploration of the areas of the brain activated during referred sensations
- Evaluation of the effects of socket modifications on phantom sensations and walking
- Phantom limb interview
Conditions studied
- Lower Limb Amputation — all drugs for Lower Limb Amputation →
Sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Who can join
18 and older, any sex, with Lower Limb Amputation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Following lower-limb amputation, the loss of somatosensory information from the missing limb renders walking less automatic, more cognitively demanding, and often asymmetric, which can lead to secondary pathologies. Hypothesis: This study is based on the hypothesis that phantom limb sensations (PLS), when coherent with the prosthetic device's movements and the phases of the gait cycle, can compensate for the loss of somatosensory feedback and thereby improve locomotion for individuals with amputation. It is further hypothesized that it is possible to artificially induce these coherent and useful sensations, notably through "referred sensations" elicited by stimulation of the residual limb (e.g., via the prosthetic socket). Objectives: The project aims to: * Determine whether the natural presence of phantom limb sensations during walking impacts gait parameters. * Confirm in a larger patient population that modifications to the prosthetic socket can induce or enhance phantom sensations that are perceived as useful for walking. * Investigate whether these perceptual changes (induced or enhanced) are associated with objective, measurable improvements in gait quality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07191795
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gait analysis
Trials testing the same drug.
- NCT06107556 — Agonist and Antagonist Muscle Activations in the Lower Limbs During Walking After Central Nervous System Injury · unknown
- NCT05913934 — Clubfeet and Twins and Gait Analysis · unknown
- NCT05576064 — Is Gait Analysis for Proposed Rotational Deformities a Useful Resource · completed
- NCT06260813 — Biomechanical and Morphological Characterization of PTTD · NA · recruiting
- NCT05127538 — Balance and Gait in Diabetic Neuropathy · NA · completed
Other recruiting trials for Lower Limb Amputation
Currently open trials in the same condition.
- NCT06556082 — Effect of PNF-Based Upper Extremity Strengthening With Core Stabilization on Fitness in Amputee Football Players · NA · active not recruiting
- NCT05830630 — Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery · NA · recruiting
Other Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est trials
Trials by the same sponsor.
- NCT06438432 — Trunk Activity Rehabilitation in Young Children With Cerebral Palsy · NA · recruiting
- NCT05650398 — Changes in Tactile Perception in People With Segmental Exclusion Syndrome · completed
- NCT05224232 — Protocole Access-Socket · NA · completed
- NCT04778111 — Segmental Exclusion of the Upper Limb and Peri-personal Space · completed
- NCT05085821 — Cardio-visual Stimulation in Augmented Reality for Pain Reduction · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07191795 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
- Last refreshed: 25 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07191795.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing